A Review of the Emerging Potential Therapy for Neurological Disorders: Human Embryonic Stem Cell Therapy
The first human embryonic stem cell (hESC) line was developed in the late nineties.
The first human embryonic stem cell (hESC) line was developed in the late nineties.
Background: Autism spectrum disorder is a neurodevelopmental disorder accompanied by weak immune system and neuroinflammation.
Human embryonic stem cell (hESC) therapy is the potential therapeutic option for the treatment of patients with aplastic anemia (AA)
Thanks for contacting ReoStem! We have received your response and we will get back to you shortly.